OBJECTIVES: The pelvic exenteration is a method of treatment in cases of recurrence or locally advanced gynecological @entity5 without distance metastases. The total pelvic exenteration has been used as salvage therapy especially for advanced @entity5 . DESIGN: The aim of study was to analyse the group of @entity1 who underwent pelvic exenteration. MATERIAL AND METHODS: A series of 13 @entity1 who underwent pelvic exenteration for advanced @entity5 at the Department of Gynecology, Medical University of @entity235  sk Poland between 1996-2003 was retrospectively reviewed. RESULTS: The more often performed exenteration in @entity1 with @entity5 was posterior pelvic exenteration in 11 cases, total pelvic exenteration in 2 cases. The mean age at diagnosis was 56 years. The estimated blood transfusion due to operation ranged from 300 ml to 3580 ml with a mean of 1200 ml. The operating time ranged from 4 hours to 7 hours 30 minutes with a mean of 6 hours and 5 minutes. @entity1 stayed in hospital from 14 to 54 days after operation with a mean 33 days. The overall complication rate after pelvic exenteration was 61.5% with 8 of the 13 @entity1 . Three times it was infection, six times wound dehiscence, in 1 case it was: ARDS, @entity2268 , @entity16 . There was no late complication. CONCLUSION: Pelvic exenteration offers the last chance for some @entity1 with @entity5 .

[The role of pelvic exenteration for the treatment of XXXX ].

@entity1 :: ('9606', 'Species') :: ['women', 'Patients', 'patients'] @entity5 :: ('MESH:D009369', 'Disease') :: ['vulvar cancer', 'gynecological malignancy', 'tumors'] @entity16 :: ('MESH:D009422', 'Disease') :: ['ureter damage'] @entity2268 :: ('MESH:D013924', 'Disease') :: ['thrombophlebitis'] @entity235 :: ('9615', 'Gene') :: ['Gda']
@entity5 :: (MESH:D009369,Disease) :: ['vulvar cancer']
